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Chemical shift indexingCaveolin is an integral membrane protein that is found in high abundance in caveolae. Both the N- and C- ter-
mini lie on the same side of the membrane, and the transmembrane domain has been postulated to form an
unusual intra-membrane horseshoe conﬁguration. To probe the structure of the transmembrane domain, we
have prepared a construct of caveolin-1 that encompasses residues 96–136 (the entire intact transmembrane
domain). Caveolin-1(96–136) was over-expressed and isotopically labeled in E. coli, puriﬁed to homogeneity,
and incorporated into lyso-myristoylphosphatidylglycerol micelles. Circular dichroism and NMR spectrosco-
py reveal that the transmembrane domain of caveolin-1 is primarily α-helical (57–65%). Furthermore, chem-
ical shift indexing reveals that the transmembrane domain has a helix–break–helix structure which could be
critical for the formation of the intra-membrane horseshoe conformation predicted for caveolin-1. The break
in the helix spans residues 108 to 110, and alanine scanning mutagenesis was carried out to probe the struc-
tural signiﬁcance of these residues. Our results indicate that mutation of glycine 108 to alanine does not
disrupt the structure, but mutation of isoleucine 109 and proline 110 to alanine dramatically alters the
helix–break–helix structure. To explore the structural determinants further, additional mutagenesis was per-
formed. Glycine 108 can be substituted with other small side chain amino acids (i.e. alanine), leucine 109 can
be substituted with other β-branched amino acids (i.e. valine), and proline 110 cannot be substituted without
disrupting the helix–break–helix structure.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Caveolae are 50 to 100 nmwide invaginations found in the plasma
membrane [1–3]. Caveolae are particularly abundant in endothelial
cells, smooth muscle cells, macrophages, cardiac myocytes, and ﬁbro-
blasts [2,3]. These structures are involved in a variety of cellular
processes including signal transduction, membrane trafﬁcking, calci-
um signaling, and lipid recycling [4]. Caveolin is the most important
protein found in caveolae, as caveolae structures are lost when the
caveolin gene is silenced [5]. Furthermore,misregulation andmutations
to caveolin have been implicated in a variety of diseases including
cancer, muscular dystrophy, Alzheimer's, and heart disease [6–10].
In addition to the caveolin protein, caveolae are enriched in cholesterol,
and sphingolipids when compared to the bulk plasma membrane [11].cerol; NMR, nuclear magnetic
troscopy; CSI, chemical shift
ce; TROSY, transverse relaxa-
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three isoforms (caveolin-1, -2, -3), although caveolin-1 is the most
ubiquitous [2]. In vivo studies show that both the N- and C- termini
of caveolin are exposed to cytoplasm [12,13]. Moreover, based on pri-
mary sequence analysis, the predicted length of the caveolin trans-
membrane domain is too long to span the membrane once, but too
short to span twice. This data has led to the postulation that the
caveolin transmembrane domain adopts a horseshoe conformation
in the membrane (Fig. 1) [12,14]. The horseshoe conformation is
thought to be critical for the ability of caveolin to curve the plasma
membrane to form caveolae by giving the transmembrane domain
of caveolin a wedge shape which asymmetrically stretches the inner
and outer leaﬂets of the bilayer. Although this horseshoe conforma-
tion is unusual, it has been observed or predicted in other membrane
proteins notably NogoC, DP1, and DGKɛ [15,16]. Furthermore, in vivo
studies have shown that the mutation of proline 110 (found in the
transmembrane domain) to alanine, alters the topology and/or orien-
tation of the caveolin protein [17]. However, the presence of the
intra-membrane horseshoe conformation has not been veriﬁed.
In the present study, we reconstituted the entire intact transmem-
brane domain (residues 96–136) of caveolin-1 into LMPG micelles to
probe its structure using NMR and circular dichroism spectroscopy.
The transmembrane domain of caveolin-1 is highly helical and dis-
plays a helix–break–helix structure. Three amino acids G108, I109,
and P110 are critical for this motif. These results strongly suggest
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Fig. 1. (A) Cartoon of caveolin-1 topology. Red denotes the transmembrane domain.
Zigzag lines denotes palmitoylation. (B) Sequence of Cav196-136.
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Fig. 2. Circular dichroism spectra of Cav196-136 (solid line) and Cav196-136 P110A
(dashed line). Minima at 208 nm and 222 nm are indicative of a highly α-helical
structure.
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of the intra-membrane horseshoe conformation.
2. Material and methods
2.1. Overexpression and puriﬁcation of Cav196-136
Cloning, expression, and puriﬁcation of uniformly 15N-labeled
Cav196-136 was performed as described in Diefenderfer et al. [18].
For compatibility with cyanogen bromide cleavage, the single methi-
onine at position 111, which is not strictly conserved, was mutated
to leucine based on sequence homology to caveolin-2 and caveolin-
3. C133 a site of cysteine palmitoylation was mutated to serine
to avoid unwanted and biologically irrelevant disulﬁde bonding.
Previous studies have shown that caveolin-1 still retains the ability
to fold correctly and trafﬁc to the plasma membrane when C133
is mutated to serine [19–21]. Expression of uniformly 15N and 13C-
labeled Cav196-136, was done according to the procedure of Marley
et al. [22]. Speciﬁc amino acid labeling was performed as described
in Truhlar et al. with slight modiﬁcation [23]. The cell growth was
done on a 1 L scale using M9 minimal media supplemented with
100 mg of the desired 15N amino acid and 500 mg each of the other
19 14N amino acids. Expression was induced at an OD600 of 0.6 using
1 mM IPTG (isopropyl β-D-1-thiogalactopyranoside) and grown for
6–8 hours at 37 °C.
2.2. Sample preparation
NMR samples were prepared by adding 500 μL of buffer (100 mM
LMPG, 100 mM NaCl, 20 mM phosphate pH 7, and 10% D2O) to a tube
containing 2.5 mg of lyophilized Cav196-136. The sample was vortexed
vigorously for 2 minutes followed by immersion in a hot water bath
(95 °C) for one minute. At this point a clear solution was obtained
with a minimal amount of precipitate. Finally, the sample was ﬁltered
through a 0.2 μm regenerated cellulose spin ﬁlter. The ﬁnal protein
concentration was approximately 1 mM. For circular dichroism stud-
ies the NMR sample was diluted 20-fold with buffer.
2.3. Circular dichroism spectroscopy
All circular dichroism experiments were performed using a JASCO
circular dichroism spectrophotometer (Easton, MD). The experi-
ments were carried out at 25 °C. Spectra were obtained from 260 to190 nm using 16 accumulations. A background spectrum containing
no caveolin protein was subtracted from the spectra containing pro-
tein. In all cases a 0.1 mm path length cuvette was used.
2.4. Two and Three dimensional NMR spectroscopy
All NMR spectra were acquired at 37 °C using a 600 MHz Bruker
Avance II spectrometer (Billerica, MA) equipped with a cryoprobe.
For analysis and backbone assignments, the following TROSY-based
pulse sequences were employed: HSQC, HNCA, and HN(CO)CA. The
spectra were processed using NMRPipe and Sparky [24,25].
2.5. Alanine scanning mutagenesis
All mutant constructs were prepared using the QuikChange site-
directed mutagenesis kit (Agilent Technologies, Santa Clara, CA).
3. Results
3.1. Circular dichroism
Fig. 2 shows the circular dichroism spectrum of Cav196-136. There
are two minima at 208 and 222 nm which is indicative of α-helical
properties. Analysis of the spectrum using the CDSSTR and K2D algo-
rithms (Dichroweb) indicates that Cav196-136 is approximately 57%
α-helical [26,27]. Mutation of proline 110 to alanine results in a cir-
cular dichroism spectrum that is remarkably similar to that of the
wild-type. Therefore, mutation of proline 110 to alanine does not
dramatically alter the secondary structure of Cav196-136.
3.2. Peak assignments
Uniformly labeled Cav196-136 (13C, 15N ) in LMPGmicelles gave the
highest quality NMR spectra [28]. To assign the backbone resonances
the following two and three dimensional TROSY-based experiments
were performed: HSQC, HNCA, and HN(CO)CA. To aid in backbone
assignments, speciﬁc amino acid labeling was employed (Phe, Ala,
Leu, Ile, and Val). The assigned 1H, 15N-TROSY spectrum is shown in
Fig. 3.
3.3. Chemical shift indexing
Fig. 4 shows the chemical shift indexing of Cav196-136. Residues
97–107 and residues 111–129 have consistently positive ΔCα's
which is indicative of α-helical structure [29]. Residues 108–110
which lie between these regions do not have positive ΔCα's. This in-
dicates breakage between the two α-helices. Residues 130–136 do
not display consistent ΔCα's indicating, most likely, a disordered
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Fig. 3. 1H-15N TROSY-HSQC spectrum of Cav196-136. The spectrum was acquired with 256 complex points in t1 (15N) and 2048 complex points in t2 (1H).
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the transmembrane domain of caveolin is displaying a helix–break–
helix structure. Based on chemical shift indexing, 65% of Cav196-136
is α-helical which agrees well with the circular dichroism data
which predicted 57% α-helicity.
3.4. Alanine scanning mutagenesis
Chemical shift indexing reveals that the break encompasses G108,
I109, and P110. To probe whether or not these speciﬁc residues were
critical for the observed helix–break–helix structure, alanine scanning
mutagenesis was employed by mutating G108, I109, and P110 indi-
vidually to alanine. Alanine was chosen because it has very “neutral”
characteristics (small chemically inert nonpolar side chain and con-
formational freedom that is similar to most amino acids). Fig. 5A
shows a comparison of the G108A spectrum to that of wild-type.
Although the resonances neighboring G108 displayed small shifts,
the bulk of the resonances remained the same. Therefore, the global
structure of Cav196-136 was retained when glycine 108 was mutatedK Y W F Y R L L S A L F G I P L A L I W
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Fig. 4. Chemical shift indexing of Cav196-136. Cav1to alanine. Fig. 5B and C shows the I109A and P110A mutations, re-
spectively. Clearly these two spectra are signiﬁcantly different from
that of the wild-type. Speciﬁcally, the chemical shift dispersion of
the spectra is greatly reduced, and the number of distinct residues
has diminished. This indicates that there was a dramatic change in
the structure when these mutations are made. Therefore, I109 and
P110 appear to be critical for stabilizing the helix–break–helix motif.
3.5. Additional mutagenesis
Based on the alanine scanningmutagenesis result, glycine 108 was
mutated to isoleucine and leucine to probe whether position 108 can
tolerate amino acids with bulky side chains. Fig. 6A and B shows that
both G108I and G108L have spectra that are signiﬁcantly different
from that of the wild-type. Therefore, position 108 can tolerate
small side chain amino acids such as glycine and alanine, but not
bulky side chain amino acids such as leucine or isoleucine.
Next, isoleucine at position 109 was mutated to leucine. Leucine
and isoleucine have very similar side chains aside from the fact thatG I Y F A I L S F L H I W A V V P S I K S
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Fig. 5. TROSY-HSQC of Cav196-136. (A) Red denotes G108A mutant and black denotes
wild-type. (B) I109A mutant. (C) P110A mutant.
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Fig. 6. TROSY-HSQC of Cav196-136. (A) G108I mutant. (B) G108L mutant.
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while it occurs off of the beta carbon in isoleucine. Fig. 7A shows
the spectrum of I109L. Overall the spectrum looks similar to that of
wild-type. Extra peaks were observed, and the resolution of the spec-
trum was mildly diminished when compared to that of the wild-type.
Fig. 7B shows the spectrum of I109L after one week. In contrast, this
spectrum is dramatically different from that of the wild-type. Thissuggests that position 109 may require a beta-branched amino acid
for structure stability. To probe this further, isoleucine 109 was mu-
tated to valine which is another beta branched amino acid. Fig. 7C
shows that the I109V spectrum overlays well with that of the wild-
type, but as expected, small changes in the resonances around posi-
tion 109 were observed. Therefore a beta-branched amino acid at
position 109 is critical for the helix–break–helix structure.
Finally, the proline at position 110 was mutated to glycine. Glycine
was chosen because it is the amino acid with the most conformational
freedom. This would give position 110 the ability to adopt a tight turn
geometry that may be necessary to stabilize the helix–break–helix
motif. Fig. 8 shows the spectrum of P110G. Although glycine has
the most conformational freedom of all twenty standard amino
acids, the spectrum of P110G was signiﬁcantly different from that of
wild-type. Therefore, proline at position 110 is critical for the helix–
break–helix structure.3.6. Discussion
Caveolin is the most important protein in caveolae, and it plays a
dual role. It is critical both structurally for facilitating the highly
curved nature of caveolae, and for interacting with a myriad of pro-
teins in various signal transduction pathways. Based on hydropathy
analysis, the transmembrane domain of caveolin is predicted to be 33
residues in length. Therefore, the transmembrane domain of caveolin
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In addition, there are no loop segments within the transmembrane
domain that would facilitate a polytopic topology. Furthermore, in
vivo studies have shown that both the N- and C- termini of caveolin
face the cytoplasm [12]. These two pieces of data have led to the postu-
lation that the transmembrane domain of caveolin forms an unusualhorseshoe or loop conformation in the membrane. Moreover, the
intra-membrane horseshoe conformation is thought to facilitate the
high-degree of membrane curvature found in caveolae. However,
there is no direct experimental data to support the postulation that the
transmembrane domain is indeed adopting a horseshoe conformation.
Based on hydropathy analysis, the transmembrane domain of
caveolin-1 is predicted to encompass residues 102–134. To allow for
a margin of error in transmembrane prediction, additional residues
are added to the N- and C- termini so that the ﬁnal construct contains
residues 96–136. Next, the transmembrane domain is reconstituted
into LMPG micelles. Circular dichroism spectroscopy reveals that
the secondary structure in the transmembrane domain is predomi-
nately α-helical (57%).
The HSQC spectrum of the caveolin-1 transmembrane domain
(Fig. 3) shows relatively sharp resonances and a high degree of chem-
ical shift dispersion which is indicative of a well-structured protein.
This shows that the transmembrane domain alone has a stable con-
formation. Chemical shift indexing (Fig. 4) reveals that the trans-
membrane domain has four distinct regions: There is an α-helix
from residues 97–107 (helix 1), a break from residues 108–110,
another α-helix from residues 111–129 (helix 2), and an unstruc-
tured region from residues 130–136. This data clearly shows that
the transmembrane domain of caveolin is displaying a helix–break–
helix structure. This result is remarkable because if the transmem-
brane domain forms a horseshoe conformation, it is expected that a
break in the helix would be necessary for the polypeptide to make a
tight turn and return to the membrane surface. Therefore, a helix-
turn-helix structure would be consistent with the caveolin trans-
membrane domain forming a wedge shape in the membrane. Impor-
tantly this wedge shape could induce the high degree of membrane
curvature observed in caveolae by asymmetrically stretching the
inner and outer leaﬂets of the bilayer. This represents, to our knowl-
edge, the ﬁrst piece of direct experimental structural data on the
intact transmembrane domain of caveolin-1. Furthermore, our data
strongly supports the premise that the transmembrane domain of
caveolin-1 alone is primarily responsible for the horseshoe conforma-
tion. Based on the chemical shift index analysis, the transmembrane
domain is approximately 65% helical which agrees well with the
circular dichroism data which shows 57% α-helicity.
The break between helix 1 and helix 2 encompasses three amino
acid residues, G108, I109, and P110. Next, alanine scanning mutagen-
esis is performed for each of the three residues to deduce the roles
of these amino acids in the transmembrane domain structure.
Comparison of the mutant G108A spectrum to that of the wild-type
1163J. Lee, K.J. Glover / Biochimica et Biophysica Acta 1818 (2012) 1158–1164spectrum shows that mutation of G108 to alanine did not signiﬁcantly
alter the structure of the caveolin transmembrane domain (Fig. 5A).
However, the mutation of G108 to leucine or isoleucine dramatically
altered the HSQC spectrum when compared to that of the wild-type
(Fig. 6). This reveals that position 108 is somewhat restricted steri-
cally, and cannot accommodate amino acids with large side chains.
Isoleucine resides at position 109. When isoleucine is mutated to
alanine, the HSQC spectrum is altered signiﬁcantly (Fig. 5B). This indi-
cates that there is a dramatic change in the structure of the trans-
membrane domain. Analysis of the I109L mutant shows a spectrum
that is mildly altered, but over time (1 week) the structure is
lost (Fig. 7A and B). This reveals that the substitution of isoleucine
for leucine produces a structure that is only meta-stable. However,
this meta-stability cannot be contributed to changes in side chain
bulkiness as leucine and isoleucine are very similar. Mutation of I109
to valine shows a spectrum that is virtually identical to that of the
wild-type revealing that valine is able to preserve the structure
(Fig. 7C). Both isoleucine and valine are β-branched amino acids. β-
branched amino acids are more conformationally restricted than
the other amino acids except for proline. Therefore at this position
a conformationally restricted amino acid is needed to stabilize the
structure.
Position 110 contains proline which is the most conformationally
restricted of all of the amino acids. It is not surprising that the proline
would be required for a helix–break–helix structure as it is often
found in places where the polypeptide makes a tight turn. Mutation
of P110 to alanine, again, results in a loss of structure showing that
it is critical at this position (Fig. 5C). Clearly, proline provides the
necessary rigidity to support the helix–break–helix structure. Glycine,
like proline, is also commonly found in places where the polypeptide
makes tight turns. Glycine is able to adopt different conformations
easily because of its conformational freedom. Mutation of P110 to gly-
cine showed that it was not a suitable substitute for proline (Fig. 8).
Therefore, at position 110, proline appears to be absolutely critical.
In summary, all three amino acids found in the break, for different
reasons, play an important role in stabilizing the helix–break–helix
structure.
As discussed earlier, the spectrum of P110A is of poor quality (in-
creased line broadening) when compared to that of the wild-type.
However, the circular dichroism spectrum of P110A (Fig. 2) is very
similar to that of the wild-type, indicating that this mutation does
not result in a global alteration of the secondary structure (α-helicity).
Furthermore, gel ﬁltration analysis (data not shown) of the P110A
mutant when compared to the wild-type reveals that large aggre-
gates are not forming. However, the data does not preclude the for-
mation of low order (dimers or trimers) aggregates. Consequently,
the poor quality of the P110A mutant spectrum could be due to sig-
niﬁcantly lower reorientation rates caused by small scale sample
aggregation. Another possibility is that the mutation inhibits the as-
sociation of the transmembrane domain with the micelles. However
this is not probable based on in vivo data which shows that the
caveolin-1 P110A mutant trafﬁcs to and inserts into the plasma mem-
brane albeit with an altered orientation [30]. We postulate that the
mutation of P110A signiﬁcantly alters the tertiary structure of the trans-
membrane domain which in turn causes small scale sample aggrega-
tion. Therefore, if we make the assumption that the break between
helix 1 and helix 2 is a turn region that supports the horseshoe con-
formation, the mutation of P110 to alanine likely causes a loss of the
horseshoe conformation.
Lastly, our results also agree with a topological model of caveolin
based solely on sequence analysis which predicted that the turn of
the polypeptide chain occurred at residues GIPM (108–111) [14].
However, our results reveal that only GIP (108–110) is involved in
the break. Overall our results provide much needed experimental
data on the structure of the transmembrane domain of caveolin, and
will help to clarify and support existing caveolin models.Acknowledgements
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